159 related articles for article (PubMed ID: 2852221)
21. Combination chemotherapy for metastatic brain tumors.
Conte PF; Giaccone G; Musella R; Calciati A
Tumori; 1981 Dec; 67(6):559-62. PubMed ID: 6278687
[TBL] [Abstract][Full Text] [Related]
22. Teniposide in the treatment of small-cell lung cancer: the influence of prior chemotherapy.
Giaccone G; Donadio M; Bonardi G; Testore F; Calciati A
J Clin Oncol; 1988 Aug; 6(8):1264-70. PubMed ID: 2842464
[TBL] [Abstract][Full Text] [Related]
23. A phase II study with teniposide (VM26) in patients with progressed or relapsed small cell lung cancer (SCLC).
Tummarello D; Guidi F; Di Furia L; Gramazio A; Menichetti E; Cellerino R
J Chemother; 1989 Feb; 1(1):64-7. PubMed ID: 2542470
[TBL] [Abstract][Full Text] [Related]
24. High dose etoposide for brain metastases of small cell lung cancer. A phase II study. The EORTC Lung Cancer Cooperative Group.
Postmus PE; Haaxma-Reiche H; Sleijfer DT; Kirkpatrick A; McVie JG; Kleisbauer JP
Br J Cancer; 1989 Feb; 59(2):254-6. PubMed ID: 2539174
[TBL] [Abstract][Full Text] [Related]
25. Teniposide: overview of its therapeutic potential in adult cancers.
Muggia FM
Cancer Chemother Pharmacol; 1994; 34 Suppl():S127-33. PubMed ID: 8070021
[TBL] [Abstract][Full Text] [Related]
26. [Treatment of anaplastic carcinoma of the lung with VP 16-213].
Sanz Ortíz J; Saiz García F
Med Clin (Barc); 1982 Oct 16-31; 79(7):322-4. PubMed ID: 6294420
[No Abstract] [Full Text] [Related]
27. VP16-213 combined with cis-platinum (CDDP) in the treatment of small cell carcinoma of the lung (SCLC).
Madrigal PA; Manga GP; Palomero I; Gomez RG
Cancer Chemother Pharmacol; 1982; 7(2-3):203-4. PubMed ID: 6282485
[No Abstract] [Full Text] [Related]
28. [Teniposide and cisplatin compared with etoposide and cisplatin for treatment of small cell lung cancer].
Fan Y; Huang ZY; Zhang YP; Sun L
Ai Zheng; 2002 Dec; 21(12):1368-71. PubMed ID: 12520751
[TBL] [Abstract][Full Text] [Related]
29. VP-16-213 therapy in patients with small-cell carcinoma of the lung after failure on combination chemotherapy.
Tempero M; Kessinger A; Lemon HM
Cancer Clin Trials; 1981; 4(2):155-7. PubMed ID: 6265110
[No Abstract] [Full Text] [Related]
30. Double-platinum chemotherapy combined with etoposide in metastatic brain tumor from small cell lung carcinoma.
Yamada SM; Yamada S; Takahashi H; Teramoto A; Nakayama H
J Neurooncol; 2005 Feb; 71(3):259-65. PubMed ID: 15735914
[TBL] [Abstract][Full Text] [Related]
31. Teniposide (VM-26), an overlooked highly active agent in small-cell lung cancer. Results of a phase II trial in untreated patients.
Bork E; Hansen M; Dombernowsky P; Hansen SW; Pedersen AG; Hansen HH
J Clin Oncol; 1986 Apr; 4(4):524-7. PubMed ID: 3007684
[TBL] [Abstract][Full Text] [Related]
32. The epipodophyllotoxin derivatives VM-26 and VP-16-213, 1976-1979, a review.
Nissen NI; Dombernowsky P; Hansen HH; Pedersen AG
Recent Results Cancer Res; 1980; 74():98-106. PubMed ID: 7003663
[TBL] [Abstract][Full Text] [Related]
33. A case of small cell lung cancer successfully treated with VM26.
Suga J; Saijo N; Shinkai T; Eguchi K; Sasaki Y; Sakurai M; Sano T; Tamura T; Morinaga S
Jpn J Clin Oncol; 1986 Jun; 16(2):123-8. PubMed ID: 3016377
[TBL] [Abstract][Full Text] [Related]
34. Etoposide in small cell lung cancer resistant to prior chemotherapy.
Asbury RF; Rubins J; Bennett JM
Cancer Treat Rep; 1983 Oct; 67(10):951-2. PubMed ID: 6313187
[No Abstract] [Full Text] [Related]
35. [New antineoplastic drugs of the podophyllotoxin derivative group].
Robak T; Płuzańska A
Pol Tyg Lek; 1983 Jan; 38(1):27-30. PubMed ID: 6346283
[No Abstract] [Full Text] [Related]
36. Cisplatin plus etoposide with and without ifosfamide in extensive small-cell lung cancer: a Hoosier Oncology Group study.
Loehrer PJ; Ansari R; Gonin R; Monaco F; Fisher W; Sandler A; Einhorn LH
J Clin Oncol; 1995 Oct; 13(10):2594-9. PubMed ID: 7595712
[TBL] [Abstract][Full Text] [Related]
37. Teniposide sometimes effective in brain metastases from non-small cell lung cancer.
Boogerd W; van der Sande JJ; van Zandwijk N
J Neurooncol; 1999 Feb; 41(3):285-9. PubMed ID: 10359149
[TBL] [Abstract][Full Text] [Related]
38. Teniposide (VM26) as second-line treatment for small cell lung cancer.
Tummarello D; Guidi F; Torresi U; Dazzi C; Cellerino R
Anticancer Res; 1990; 10(2A):397-9. PubMed ID: 2161198
[TBL] [Abstract][Full Text] [Related]
39. Etoposide (VP 16-213; VePesid).
Med Lett Drugs Ther; 1984 May; 26(661):48-9. PubMed ID: 6325855
[No Abstract] [Full Text] [Related]
40. VM26 (NSC-122819): a clinical study in advanced cancer of the lung and ovary.
Samson MK; Baker LH; Talley RW; Fraile RJ
Eur J Cancer (1965); 1978 Dec; 14(12):1395-9. PubMed ID: 216556
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
